

share
17β-Hydroxy-5α-Androstane-3,6-Dione CAS NO 899-39-8
Unit Price:
CAS No.:899-39-8
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
17β-Hydroxy-5α-Androstane-3,6-Dione is a high-purity steroidal intermediate of significant importance in advanced pharmaceutical synthesis and research. This compound serves as a critical building block for the development of novel therapeutic agents, particularly in the field of endocrinology and hormone-related research. It is primarily required by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic research institutions engaged in steroid chemistry and drug discovery.
Application
- Pharmaceutical Intermediate: A key precursor in the synthesis of complex steroid-based active pharmaceutical ingredients (APIs) and novel drug candidates.
- Biochemical Research: Used as a reference standard and a starting material in metabolic pathway studies and enzyme inhibition assays related to steroidogenesis.
- Hormone Analog Development: Serves as a core structure for the research and development of modified androstane derivatives with targeted biological activity.
- Fine Chemical Synthesis: Employed in multi-step organic synthesis for creating specialized steroidal compounds for various investigational purposes.
Basic Information
| Product Name | 17β-Hydroxy-5α-Androstane-3,6-Dione |
| CAS No. | 899-39-8 |
| Molecular Formula | C19H28O3 |
| Molecular Weight | 304.43 g/mol |
| Synonyms | 5α-Androstane-3,6-dione-17β-ol; 17β-Hydroxy-5α-androstane-3,6-dione; 3,6-Diketo-5α-androstan-17β-ol; 5α-Androstan-17β-ol-3,6-dione; Androstanedione derivative |
| EINECS | Contact for details |
Quality Control
Our 17β-Hydroxy-5α-Androstane-3,6-Dione is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles, typically verified by HPLC, IR, and other relevant analytical techniques. We adhere to cGMP principles for pharmaceutical intermediates, ensuring reliable quality for critical research and development applications.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification (IR) | Conforms to reference spectrum |
| Assay (HPLC) | ≥ 98.0% |
| Loss on Drying | ≤ 0.5% |
| Related Substances (HPLC) | Individual impurity ≤ 0.5% Total impurities ≤ 1.5% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Withaferin A CAS NO 5119-48-2


4,16-Androstadien-3-One CAS NO 4075-07-4


4-Pregnen-3,6,20-Trione CAS NO 2243-08-5


Cortexolone CAS NO 152-58-9


Uzarin CAS NO 20231-81-6


5-α-Androstane CAS NO 438-22-2


5-Pregnene-3Alpha-Ol-20-One CAS NO 19037-28-6


Scillaren A CAS NO 124-99-2


Smilagenin CAS NO 126-18-1


Sarsasapogenin CAS NO 126-19-2


4-Pregnene-17,20Beta,21-Triol-3-One CAS NO 128-19-8


Pregnanedione CAS NO 128-23-4


Digitoxigenin CAS NO 143-62-4


Pregnenolone CAS NO 145-13-1


Anordiol CAS NO 1045-29-0


16-Dehydropregnenolone Oxime CAS NO 1045-71-2


17-Ethylpregn-4-Ene-3,20-Dione CAS NO 1048-01-7


Tetrahydroxypregnenolone CAS NO 1050-84-6


Androstanolone 17-Benzoate CAS NO 1057-07-4


Gitoxigenin 3-Acetate CAS NO 1059-21-8
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






